Results 251 to 260 of about 885,440 (356)

A Commentary on "Magnetic Resonance Spectroscopy Lipids Peak May Serve as a Potential Biomarker for Back Pain in Intervertebral Disc Degeneration: An Integrative Metabolomics and Proteomics Study Investigating the Role of the Lipid Droplets-Interleukin-17 Inflammatory Axis". [PDF]

Neurospine
Vadalà G, Ambrosio L, Russo F, Denaro V.   +3 more
europepmc   +1 more source

Distinctive expression pattern of interleukin-17 cytokine family members in colorectal cancer

, 2015
Ahmed Al‐Samadi, Shirin Moossavi, Abdelhakim Salem, Masoud Sotoudeh, Sarianna M. Tuovinen, Yrjö T. Konttinen, Tuula Salo, Faraz Bishehsari   +7 more
openalex   +2 more sources

A Microbiota‐ and IL‐15‐Dependent Innate‐Like B Cell Progenitor Expressing E4BP4

Advanced Science, EarlyView.
This work identifies CD3.NKp46.CD19.NK1.1. NK‐B cells enriched in PDK1‐deficient yet present in wild‐type bone marrow. IL‐15 (via CD122) and TLR9‐microbiota signaling maintain their E4BP4 expression. These cells demonstrate innate immunity, preferentially differentiate into B cells, and unveil a novel microbiota‐ and IL‐15‐dependent regulatory pathway ...
Junming He, Xinlei Hou, Xiaomei Feng, Yayun Dong, Mengqi Ren, Surong Deng, Xinru Yang, Donglin Chen, Lingna Zhao, Shasha Chen, Meixiang Yang, Zhongjun Dong   +11 more
wiley   +1 more source

Effects of Chinese Medicine on modulating interleukin-17-regulated macrophages in coronary heart disease. [PDF]

Front Pharmacol
Liu Q, Liu P, Li C, Zhao Z, Wang D, Liu Q, Yang H.   +6 more
europepmc   +1 more source

NAD+‐Dependent Enzyme SIRT3 Limits Intestinal Epithelial Cell Functions Through NAD+ Synthesis Pathway in Colorectal Cancer

Advanced Science, EarlyView.
Microbiota‐derived quinolinic acid is used as an alternative source of replenishing the intracellular NAD+ pool induced by SIRT3 deficiency to regulate intestinal epithelial cell and T cell function, which has implications for targeting intestinal epithelial cells as an approach to the treatment of immune‐associated diseases, including colorectal ...
Ruiying Niu, Yingjie Dong, Jianghui Tong, Jingxuan Xia, Longhao Zhao, Zi Geng, Yingxin Lin, Jinghe Zhang, Xinyi Liu, Manqi Fang, Xi Jin, Yujing Bi, Guangwei Liu   +12 more
wiley   +1 more source

Brand-to-brand nonmedical switching among interleukin-17 inhibitors or other biologics: Implications of a formulary change. [PDF]

J Manag Care Spec Pharm
Fendrick AM, Mittal M, Peng Y, Johns B, Holmes C, Liu Y.   +5 more
europepmc   +1 more source

Interleukin-6, Interleukin-17 and Transforming Growth Factor-Beta are Overexpressed in Newly Diagnosed Tuberculosis Patients; Potent Biomarkers of Mycobacterial Infection

, 2019
Fakhri Sadat Seyedhosseini, Saeed Mohammadi, Mojtaba Zare Ebrahimabad, Behnaz Khodabakhshi, Abdollah Abbasi, Yaghoub Yazdani   +5 more
openalex   +2 more sources

A Rationally Engineered Spleen‐Tropic One‐Component Lipid‐mRNA Complex (OncoLRC) for Cancer Vaccines

Advanced Science, EarlyView.
OncoLRC, a one‐component lipid‐mRNA complex, enables efficient spleen‐targeted delivery at an exceptionally low lipid‐to‐mRNA mass ratio (1.5:1), robustly activates immune responses, inhibits tumor growth, and synergizes with checkpoint blockade, presenting a next‐generation platform for mRNA vaccines.
Qimeng Yin, Chenchen Zhang, Jiahao Li, Kun Huang, Min Qiu   +4 more
wiley   +1 more source

Case Report: Secukinumab (Interleukin-17 Inhibitor) and Ulcerative Colitis Flare - the Double-Edged Sword. [PDF]

Case Rep Gastroenterol
Ongay J, Candel I, Bitton A, Afif W, Bessissow T, Lakatos PL.   +5 more
europepmc   +1 more source

Circulating interleukin 17 is increased in the acute stage of Kawasaki disease

, 2003
Myung Hyun Sohn, SY Noh, Woochul Chang, KM Shin, D S Kim   +4 more
openalex   +2 more sources